SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-23-039523
Filing Date
2023-11-06
Accepted
2023-11-06 16:06:25
Documents
52
Period of Report
2023-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1036689
2 ex31-1.htm EX-31.1 20134
3 ex31-2.htm EX-31.2 20443
4 ex32-1.htm EX-32.1 7863
5 ex32-2.htm EX-32.2 7806
  Complete submission text file 0001493152-23-039523.txt   3661371

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE indp-20230930.xsd EX-101.SCH 23522
7 XBRL CALCULATION FILE indp-20230930_cal.xml EX-101.CAL 40223
8 XBRL DEFINITION FILE indp-20230930_def.xml EX-101.DEF 69040
9 XBRL LABEL FILE indp-20230930_lab.xml EX-101.LAB 261388
10 XBRL PRESENTATION FILE indp-20230930_pre.xml EX-101.PRE 202115
46 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 337678
Mailing Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019
Business Address 3 COLUMBUS CIRCLE 15TH FLOOR NEW YORK NY 10019 (646) 427-2727
Indaptus Therapeutics, Inc. (Filer) CIK: 0001857044 (see all company filings)

IRS No.: 863158720 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40652 | Film No.: 231379992
SIC: 2834 Pharmaceutical Preparations